Delivery Order SPE2DB22D1202-SPE2DB25FUZN2
Award Date
5/8/25
Potential Completion Date
5/9/25
Potential Value
$4.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,809.54 firm-fixed-price delivery order is for 4,556,517,806 units of the medication Vyvanse 30 mg capsules. The contract has an ultimate completion date of March 10, 2022 and was awarded on March 9, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,874.93 firm fixed-price delivery order contract is for the supply of 4,566,693,094 units of the prescription medication Vyvanse 30 mg capsules. The contract has an ultimate completion date of December 12, 2024 and was awarded on December 11, 2024. The contract is not designated as a set-aside. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,916.18 Firm Fixed Price Delivery Order is for the supply of 4,567,986,060 units of Vyvanse 30 mg capsules. The contract has an ultimate completion date of April 22, 2025 and is not set-aside. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,510.34 delivery order contract is for the provision of 4,567,984,172 units of Vyvanse 30 mg capsules. The contract is not set aside and is a firm fixed-price delivery order. It is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 held by AmerisourceBergen Drug Corp with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,984.58, is a delivery order for the supply of 4,566,802,553 units of the medication Vyvanse 30 mg capsule. The contract has an ultimate completion date of December 30, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,154.76 firm-fixed-price delivery order is for the supply of 4,568,202,524 units of the medication Vyvanse 30 mg capsules. The contract has a period of performance through May 12, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,486.46 firm-fixed-price delivery order contract is for the supply of 4,567,299,122 units of Vyvanse 10 mg capsules. The contract has an ultimate completion date of February 19, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,960.32 firm fixed-price delivery order is for the supply of 4,566,364 units of the medication Vyvanse 10 mg capsules. The contract has an ultimate completion date of November 8, 2024. AmerisourceBergen maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,614.56 firm fixed-price delivery order is for the supply of 4,568,164,860 units of the prescription medication Vyvanse 50 mg capsules. The contract has a performance period extending to May 7, 2025. This award is not associated with a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,337.70 delivery order contract is for the supply of 100-count capsules of the medication Vyvanse 30 mg. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 21, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...